Similar articles

• Hepatic arterial infusion: the beginning of the combination era.

  Pestalozzi BC, Gruttadauria S, Clavien PA. Pestalozzi BC, et al. J Clin Oncol. 2008 May 1;26(13):2231-2; author reply 2232-3. doi: 10.1200/JCO.2008.16.5399. J Clin Oncol. 2008. PMID: 18445857 No abstract available.
• [A study of regional chemotherapy: hepatic arterial infusion for metastatic liver tumors].

  Takahashi T, Misuta K, Masui H, Ike H, Ohki S, Shimada H. Takahashi T, et al. Gan To Kagaku Ryoho. 1994 Sep;21(13):2155-7. Gan To Kagaku Ryoho. 1994. PMID: 7944427 Clinical Trial. Japanese.
• Folfox4 regimen administered through combined hepatic arterial and systemic infusion for treatment of colorectal cancer with unresectable liver metastases.

  Guan M, Chen SC, Ying HY, Zhao L, Li XY, Zhou JF, Shao YJ, Yang XD, Lin Y, Ning XH, Bai CM. Guan M, et al. Chin Med J (Engl). 2012 Oct;125(20):3640-5. Chin Med J (Engl). 2012. PMID: 23075717
• Intraarterial infusion chemotherapy for unresectable hepatic metastases from colorectal cancer.

  Fujii M. Fujii M. Gan To Kagaku Ryoho. 1996 Sep;23(11):1381-4. Gan To Kagaku Ryoho. 1996. PMID: 8854759 Review. No abstract available.
• Hepatic artery infusional chemotherapy for colorectal liver metastases.

  Sasson AR, Watson JC, Sigurdson ER. Sasson AR, et al. Cancer Treat Res. 2001;109:279-98. doi: 10.1007/978-1-4757-3371-6_16. Cancer Treat Res. 2001. PMID: 11775442 Review. No abstract available.